Literature DB >> 16539861

Hyperbaric oxygen therapy in chronic pain management.

Senol Yildiz1, Gunalp Uzun, M Zeki Kiralp.   

Abstract

Chronic pain is one of the frequently encountered clinical problems that is difficult to cure. Hyperbaric oxygen (HBO) therapy has been reported in chronic pain syndromes with promising results. In this review, we focus on the effectiveness of HBO in fibromyalgia syndrome, complex regional pain syndrome, myofascial pain syndrome, migraine, and cluster headaches. HBO may be beneficial if appropriate patients are selected. HBO is a reliable method of treatment. However, physicians performing HBO must be aware of oxygen toxicity. Another problem regarding HBO is the scarcity of centers administering it. Further research is required focusing on the optimal treatment protocol, the cost/benefit ratio, and the safety of HBO in chronic pain management.

Entities:  

Mesh：

Year:  2006        PMID： 16539861     DOI： 10.1007/s11916-006-0019-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


  29 in total

1.  A randomized, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine.

Authors:  O S Eftedal; S Lydersen; G Helde; L White; A O Brubakk; L J Stovner
Journal:  Cephalalgia       Date:  2004-08       Impact factor: 6.292

2.  [The treatment of a complex regional pain syndrome].

Authors:  N V Tuter; A B Danilov; L V Poliakova
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  1997

3.  [Morphology and pathogenesis of soft-tissue rheumatism].

Authors:  H G Fassbender; K Wegner
Journal:  Z Rheumaforsch       Date:  1973 Sep-Oct

4.  Hyperbaric oxygen and the reflex sympathetic dystrophy syndrome: a case report.

Authors:  G Peach
Journal:  Undersea Hyperb Med       Date:  1995-12       Impact factor: 0.698

5.  Hyperbaric oxygen reduces cerebral blood flow by inactivating nitric oxide.

Authors:  I T Demchenko; A E Boso; P B Bennett; A R Whorton; C A Piantadosi
Journal:  Nitric Oxide       Date:  2000-12       Impact factor: 4.427

6.  Hyperbaric oxygen treatment of active cluster headache: a double-blind placebo-controlled cross-over study.

Authors:  A I M Nilsson Remahl; R Ansjön; F Lind; E Waldenlind
Journal:  Cephalalgia       Date:  2002-11       Impact factor: 6.292

Review 7.  Myofascial pain: diagnosis and management.

Authors:  Steven B Graff-Radford
Journal:  Curr Pain Headache Rep       Date:  2004-12

8.  Hyperbaric oxygen in the treatment of migraine with aura.

Authors:  J R Wilson; B H Foresman; R G Gamber; T Wright
Journal:  Headache       Date:  1998-02       Impact factor: 5.887

9.  A new treatment modality for fibromyalgia syndrome: hyperbaric oxygen therapy.

Authors:  S Yildiz; M Z Kiralp; A Akin; I Keskin; H Ay; H Dursun; M Cimsit
Journal:  J Int Med Res       Date:  2004 May-Jun       Impact factor: 1.671

10.  Preventive effects of hyperbaric oxygen in cluster headache.

Authors:  J Pascual; G Peralta; U Sánchez
Journal:  Headache       Date:  1995-05       Impact factor: 5.887
View more
  10 in total

1.  Reversible widespread brain 18F-FDG PET hypometabolism in chronic fatigue syndrome treated by hyperbaric oxygen therapy.

Authors:  E Mairal; B Barberon; N Laine; M Coulange; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-09       Impact factor: 9.236

2.  Hyperbaric Oxygen Prevents Cognitive Impairments in Mice Induced by D-Galactose by Improving Cholinergic and Anti-apoptotic Functions.

Authors:  Chunxia Chen; Luying Huang; Zhihuan Nong; Yaoxuan Li; Wan Chen; Jianping Huang; Xiaorong Pan; Guangwei Wu; Yingzhong Lin
Journal:  Neurochem Res       Date:  2017-01-11       Impact factor: 3.996

3.  Hyperbaric oxygen treatment produces an antinociceptive response phase and inhibits astrocyte activation and inflammatory response in a rat model of neuropathic pain.

Authors:  Bai-Song Zhao; Ling-Xin Meng; Yuan-Yuan Ding; Yan-Yan Cao
Journal:  J Mol Neurosci       Date:  2014-01-04       Impact factor: 3.444

4.  Effects of hyperbaric oxygen on pain-related behaviors and nitric oxide synthase in a rat model of neuropathic pain.

Authors:  Guang Han; Lu Li; Ling-Xin Meng
Journal:  Pain Res Manag       Date:  2013 May-Jun       Impact factor: 3.037

5.  Hyperbaric oxygen therapy can diminish fibromyalgia syndrome--prospective clinical trial.

Authors:  Shai Efrati; Haim Golan; Yair Bechor; Yifat Faran; Shir Daphna-Tekoah; Gal Sekler; Gregori Fishlev; Jacob N Ablin; Jacob Bergan; Olga Volkov; Mony Friedman; Eshel Ben-Jacob; Dan Buskila
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

6.  The NO-cGMP-PKG signal transduction pathway is involved in the analgesic effect of early hyperbaric oxygen treatment of neuropathic pain.

Authors:  Yuanyuan Ding; Peng Yao; Tao Hong; Zhenkai Han; Baisong Zhao; Weimin Chen
Journal:  J Headache Pain       Date:  2017-05-03       Impact factor: 7.277

7.  The analgesic effect of early hyperbaric oxygen treatment in chronic constriction injury rats and its influence on nNOS and iNOS expression and inflammatory factor production.

Authors:  Yuanyuan Ding; Peng Yao; Tao Hong; Hongxi Li; Yongqiang Zhu; Zhenkai Han; Guangyu Zhou
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.395

8.  The effect of nitrous oxide in comparison to oxygen combined with fentanyl on the hospitalization time and pain reduction in renal colic patients at emergency department.

Authors:  Omid Ahmadi; Amir Shirvani Dehkordi; Farhad Heydari; Mohammad Nasr Esfahani; Behzad Mahaki
Journal:  J Res Med Sci       Date:  2018-02-20       Impact factor: 1.852

9.  Effects of Ovariohysterectomy and Hyperbaric Oxygen Therapy on Systemic Inflammation and Oxidation in Dogs.

Authors:  Anais Gautier; Emily C Graff; Lenore Bacek; Eric J Fish; Amelia White; Lee Palmer; Kendon Kuo
Journal:  Front Vet Sci       Date:  2020-01-15

10.  Early hyperbaric oxygen effects on neuropathic pain and nitric oxide synthase isoforms in CCI rats.

Authors:  Yuanyuan Ding; Peng Yao; Tao Hong; Zhenkai Han; Baisong Zhao; Weimin Chen; Guangyu Zhou
Journal:  Oncotarget       Date:  2018-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.